Compare VMET & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VMET | SIBN |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 956.7M | 778.8M |
| IPO Year | 2025 | 2018 |
| Metric | VMET | SIBN |
|---|---|---|
| Price | $10.27 | $18.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $23.88 |
| AVG Volume (30 Days) | 412.2K | ★ 482.3K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | $185.47 | $16.95 |
| Revenue Next Year | $16.05 | $14.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $8.48 | $11.48 |
| 52 Week High | $13.81 | $21.89 |
| Indicator | VMET | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 50.01 |
| Support Level | $8.53 | $18.34 |
| Resistance Level | $13.56 | $19.60 |
| Average True Range (ATR) | 0.44 | 0.66 |
| MACD | -0.02 | -0.15 |
| Stochastic Oscillator | 32.43 | 14.36 |
Versamet Royalties Corp is a diversified metals royalty and streaming company with exposure to a range of resource royalties and streams including gold, silver, copper, zinc, graphite and uranium, across a variety of jurisdictions. The Company's operating segments are considered to be its individual royalties, streams and the Greenstone gold interest.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.